IVIG HUITIAN is a sterile, purified product made from pooled plasma of 1000 or more healthy donors.

Clinical specialties which utilize IVIG HUITIAN are hematology, neurology, immunology, nephrology, rheumatology, dermatology etc.

20 ml IVIG HUITIAN is used in pediatric population.

It is given to newborn babies who have neonatal jaundice due to Rh and ABO incompatibilities.

Furthermore, IVIG is administered in premature babies and to babies with low birth weight.

Also, it is given to babies who are suffering from neonatal sepsis.

50 ml IVIG HUITIAN is used in adults.

The following list for the use of IVIG HUITIAN is not exhaustive:

Replacement therapy in adults, and children and adolescents (0-18 years) in:

• Primary immunodeficiency syndromes with impaired antibody production
• [Severe Combined Immunodeficiency (SCID), X linked agammagobulinemia (XLA), Hyper- IgM syndromes, Wiskott Aldrich Syndrome (WAS), Common Variable Immunodeficiency (CVID) and others.]
• Hypogammaglobulinemia and recurrent bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.
• Hypogammaglobulinemia and recurrent bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunization.
• Hypogammaglobulinemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).
• Congenital AIDS with recurrent bacterial infections.

Immunomodulation in adults, and children and adolescents (0-18 years) in:

• Neurology
• Guillain Barré syndrome
• Myasthenia Gravis
• Multifocal motor neuropathy
• Chronic inflammatory demyelinating polyradiculoneuropathy. Only limited experience is available of use of intravenous immunoglobulins in children with CIDP.
• Paraprotein associated demyelinating neuropathy (IgM, IgG or IgA)
• Dermatomyositis/ Polymyositis/ Inclusion body myositis (IBM) (not in rapidly progressing IBM)
• Haematology
• Primary immune thrombocytopenia (ITP), in patients at high risk of bleeding or prior to surgery to correct the platelet count.
• Alloimmune thrombocytopenia (foeto-maternal/neonatal)
• Haemolytic disease of the newborn
• Allogenic bone marrow transplantation
• Dermatology
• Toxic epidermal necrolysis
• Stevens Johnson Syndrome
• Kawasaki disease

Step 1; Initially for half an hour administer at a rate of 0.01-0.02 ml/kg body weight/minute then gradually increase the rate up to 0.08 ml/kg body weight/minute if well tolerated by the patient.

Step 2; The dose and dosage regimen for IVIG HUITIAN varies and depends on a particular indication.

The dose and dosage regimen for IVIG HUITIAN varies and depends on a particular indication.

1.0g/20ml per vial

2.5g/50ml per vial

Store the product at 2-8 °C.

Do not freeze the product.